Cephalosporins: Difference between revisions
ClaireLewis (talk | contribs) |
Ostermayer (talk | contribs) (Text replacement - "Ceftriaxone" to "Ceftriaxone") |
||
| Line 1: | Line 1: | ||
==1st Generation== | ==1st Generation== | ||
*Skin and soft tissue infections (why is agent of choice before generalized symptoms) | *Skin and soft tissue infections (why is agent of choice before generalized symptoms) | ||
*[[ | *[[[[Ceftriaxone]]_Cross-reactivity|Cross-reactivity of PCN]] allergy <10% | ||
==2nd Generation== | ==2nd Generation== | ||
Revision as of 21:26, 27 January 2017
1st Generation
- Skin and soft tissue infections (why is agent of choice before generalized symptoms)
- [[Ceftriaxone_Cross-reactivity|Cross-reactivity of PCN]] allergy <10%
2nd Generation
- Intestinal anaerobes (why is agent of choice for colorectal sx)
- Largely displaced by 3rd gen agents
3rd Generation
- Drug of choice for serious infections due to:
- Klebsiella
- Enterobacter
- Proteus
- Haemophilus
- Gonorrhea
- Lyme Disease
- Meningitis (+ vanc and ampicillin)
- Pseudomonas meningitis (+ AG)
4th Generation
- Resistant, nosocomial infections
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
See Also
References
Goodman & Gilman's Pharmacology